Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
Cancer Microenviron. 2015 Apr;8(1):43-4.
doi: 10.1007/s12307-015-0165-y.